Atlas Trials

Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy

Clinical trial NCT01332149 · COMPLETED

Trial details

NCT number
NCT01332149
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetic Neuropathy, Painful
Start date
2011-07-01
Primary completion
2014-04-01
Enrollment
626

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.